Most Recent
In ME Bank case, ASIC argues clock doesn’t run on serious corporate crime
The Australian Securities and Investments Commission is challenging a ruling that threw out half the criminal charges against direct bank Members Equity, arguing the statute of limitations doesn't apply to serious corporate misconduct.
BHP’s vaccination policy at Queensland coal mines found to be lawful
BHP's policy requiring Queensland workers to be vaccinated against COVID-19 and show proof of the jab has withstood a challenge from mining unions that claimed the rule was unreasonable and breached the Privacy Act.
Shell wins more in ATO appeal over $2.3B gas exploration deduction
An appeals court has unanimously rejected the Commissioner of Taxation’s latest bid to block Shell’s $2.3 billion tax deduction for the cost of exploration activities conducted as part of the Browse LNG project off the coast of Western Australia.
Nut having it: M&M maker Mars taken to court in trade mark stoush
The world's largest macadamia grower has launched an appeal of an IP Australia decision that found its logo mark was deceptively similar to US confectionary giant Mars’ trade marks for its flagship candy M&Ms.
Mayfair 101 appeals $30M judgment in ASIC’s misleading advertising case
Embattled investment group Mayfair 101 is challenging a judge's decision last month to slug it with a $30 million penalty for engaging in misleading and deceptive advertising.
‘Unlawful greed’: AFP deploys strike force to investigate RAT price gouging
The Australian Federal Police is cracking down on COVID-19 rapid antigen test price gouging, deploying a zero-tolerance strike team to investigate “outrageous” markups referred by the Australian Competition and Consumer Commission.
Law firm accused of ‘head in the sand’ dodges costs in failed dismissal case
A law firm has escaped an order for costs sought by a Melbourne city council that argued the firm had turned a blind eye to a client’s lack of credibility in an unfair dismissal case.
‘Inherently implausible’: Generic Partners loses fight with Neurim over melatonin drug patent
Israeli drug company Neurim Pharmaceuticals has won an eight month extension to apply for a grace period for its melatonin tablet patent to treat children with autism spectrum disorder after Australian company Generic Partners lost its "inherently implausible" opposition to the patent.
Dixon Advisory files for administration, blaming class actions
Embattled wealth advisor Dixon Advisory has filed for administration, saying its potential liability in two class actions and a $7.2 million penalty it agreed to pay in ASIC proceedings mean it is likely to become insolvent in the future.
ExxonMobil takes $182M dispute with ATO to court
Oil company ExxonMobil has appealed decisions by the Australian Taxation Office to refuse deductions on profits from the sale of petrol from the largest oil field in Australia, claiming its taxable profits over four years should be reduced by $181.8 million.